Pelletizer is Designed for Die-Face Cutting of Hot-Melt Extruded Drugs

Article

The Leistritz LHLG series air-quench pelletizer mates with an extruder and enables die-face cutting of pellets in air for water-soluble pharmaceutical formulations.

The Leistritz LHLG pelletizer on the ZSE-18 twin-screw extruder. Image courtesy of Leistritz.

The Leistritz LHLG series air quench pelletizer mates with an extruder and enables die-face cutting of pellets in air for water-soluble, highly filled, and foamed formulations that are typically used for pharmaceutical and nutraceutical products. The die is electrically heated, and the flow geometry is matched with the formulation and throughput rate.  The die, blades, and all contact areas are fabricated of hardened stainless, tool, and carbide steels.  Standard features include:

  • Electrically heated pelletizing die

  • Self-aligning cutter hub with replaceable blades driven by AC motor

  • Manually adjusted blades for allowable wear

  • Stainless-steel cutting chamber with sight glass and safety interlock

  • Height-adjustable support cart on tracks

  • Optional, chamber-misting attachments for sticky formulations.

A blower facilitates initial cooling and transport to a secondary cooling and transport mechanism, such as high-velocity venturi blowers, vacuum systems, cyclones, and vibratory cooling/classification equipment. GMP-class systems are available for medical and pharmaceutical environments.

Leistritz has installed LHLG pelletizers in its New Jersey process laboratory to test formulations for use with its ZSE-18, ZSE-27, and ZSE-50 MAXX model twin-screw extruders.

Source: Leistritz

Recent Videos
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Related Content